Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Inoue A, Kobayashi K, Usui K. et al
North East Japan Gefitinib Study Group. First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy.

J Clin Oncol 2009;
27 (09) 1394-1400

Bibliographische Angaben herunterladen

Aufrufen in: